Disproportionality analysis of adverse reaction signals for novel tetracycline antibiotics based on the FDA adverse event reporting system database

doi:10.3969/j.issn.1672-3384.2024.12.008

Biqing LIU, Xiangrong BAI

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (12) : 46-53.

PDF(614 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (12) : 46-53. DOI: 10.3969/j.issn.1672-3384.2024.12.008

Original Article

Disproportionality analysis of adverse reaction signals for novel tetracycline antibiotics based on the FDA adverse event reporting system database

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(12): 46-53 https://doi.org/10.3969/j.issn.1672-3384.2024.12.008

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(614 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2024-09-03	2024-12-20
Issue Date
2025-01-25

Please choose a citation manager

Content to export